BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20528922)

  • 21. Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation.
    Gopisetty G; Xu J; Sampath D; Colman H; Puduvalli VK
    Oncogene; 2013 Jun; 32(26):3119-29. PubMed ID: 22945648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.
    Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS
    J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype.
    Yang WJ; Song MJ; Park EY; Lee JJ; Park JH; Park K; Park JH; Kim HP
    Mol Cells; 2013 Oct; 36(4):368-75. PubMed ID: 23996530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sp1-mediated transcriptional regulation of NFBD1/MDC1 plays a critical role in DNA damage response pathway.
    Bu Y; Suenaga Y; Ono S; Koda T; Song F; Nakagawara A; Ozaki T
    Genes Cells; 2008 Jan; 13(1):53-66. PubMed ID: 18173747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of the human 5-HT7 receptor gene and characterization of its promoter region.
    Laenen K; Haegeman G; Vanhoenacker P
    Gene; 2007 Apr; 391(1-2):252-63. PubMed ID: 17321075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sp1-like sequences mediate human caspase-3 promoter activation by p73 and cisplatin.
    Sudhakar C; Jain N; Swarup G
    FEBS J; 2008 May; 275(9):2200-13. PubMed ID: 18384375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1.
    Soond SM; Barry SP; Melino G; Knight RA; Latchman DS; Stephanou A
    Cell Cycle; 2008 May; 7(9):1214-23. PubMed ID: 18418051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription of promoter from the human APRIL gene regulated by Sp1 and NF-kB.
    Xu J; Ding WF; Shao KK; Wang XD; Wang GH; Li HQ; Wang HM
    Neoplasma; 2012; 59(3):341-7. PubMed ID: 22296504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts.
    Le Mée S; Fromigué O; Marie PJ
    Exp Cell Res; 2005 Jan; 302(1):129-42. PubMed ID: 15541732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons.
    Benosman S; Meng X; Von Grabowiecki Y; Palamiuc L; Hritcu L; Gross I; Mellitzer G; Taya Y; Loeffler JP; Gaiddon C
    J Biol Chem; 2011 Dec; 286(50):43013-25. PubMed ID: 22002055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the promoter of human extracellular matrix metalloproteinase inducer (EMMPRIN).
    Liang L; Major T; Bocan T
    Gene; 2002 Jan; 282(1-2):75-86. PubMed ID: 11814679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of Sp1/Sp3 to the proximal promoter of the hMOR gene is enhanced by DAMGO.
    Xu Y; Carr LG
    Gene; 2001 Aug; 274(1-2):119-28. PubMed ID: 11675004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hydroxyurea on the promoter occupancy profiles of tumor suppressor p53 and p73.
    Huang V; Lu X; Jiang Y; Wang JY
    BMC Biol; 2009 Jun; 7():35. PubMed ID: 19558638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional activation of Mina by Sp1/3 factors.
    Lian S; Potula HH; Pillai MR; Van Stry M; Koyanagi M; Chung L; Watanabe M; Bix M
    PLoS One; 2013; 8(12):e80638. PubMed ID: 24324617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural analysis of the cancer-specific promoter in mesothelin and in other genes overexpressed in cancers.
    Ren YR; Patel K; Paun BC; Kern SE
    J Biol Chem; 2011 Apr; 286(14):11960-9. PubMed ID: 21288909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sp1 and AP2 regulate but do not constitute TATA-less human TAF(II)55 core promoter activity.
    Zhou T; Chiang CM
    Nucleic Acids Res; 2002 Oct; 30(19):4145-57. PubMed ID: 12364593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma.
    Yan Y; Dalmasso G; Sitaraman S; Merlin D
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G535-45. PubMed ID: 17023546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
    Xia T; Zeng G; Gao L; Yu RK
    Gene; 2005 May; 351():109-18. PubMed ID: 15890474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors.
    Vilgelm AE; Hong SM; Washington MK; Wei J; Chen H; El-Rifai W; Zaika A
    Oncogene; 2010 Oct; 29(43):5861-8. PubMed ID: 20676143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.